Molecular Cargo of Exosomes in Prostate Cancer: A Multi-Omics Perspective on Liquid Biopsies
Genes · 01.12.2025 · 16 (12) · 1437
DOI: 10.3390/genes16121437 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 01.12.2025. Verfasst von Roxana Andra Coman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, MedLife Humanitas Hospital, 400664 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Exosomes, Prostatic Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prostate cancer is one of the most common cancers affecting men, and finding better ways to detect and monitor it remains a top priority in oncology. In recent years, scientists have focused their attention on different classes of extracellular bodies, among them the small ones called exosomes. Exosomes are nanoscale extracellular vesicles (30–200 nm) released into body fluids, where they transport molecular cargo reflective of their cell of origin. Instead of serving as liquid biopsies themselves, exosomes present in accessible fluids such as plasma and urine can be analyzed as part of minimally invasive liquid biopsy strategies without the need for surgery or tissue sampling. In prostate cancer, exosomes are not just passive carriers: they actively influence how cancer grows, spreads, and responds to treatment. Exosomes can be extracted from simple fluid samples, opening the door to faster, safer, and more personalised approaches to diagnosis and care. Exosome content is analysed for the molecular profiling of tumours, including genomics, transcriptomics, proteomics, and metabolomics. This has led to the discovery of new biomarkers that may help detect prostate cancer earlier, predict its aggressiveness, and monitor the effectiveness of treatment. This review synthesizes current multi-omics data on exosomal cargo in prostate cancer, highlighting diagnostic, prognostic, and therapeutic implications as well as existing challenges to clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, MedLife Humanitas Hospital, 400664 Cluj-Napoca, Romania.
- Genomics Department, MEDFUTURE Institute of Biomedical Research, Iuliu-Hatieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
- Doctoral School, Iuliu-Hatieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
- Academy of Medical Sciences, 030167 Bucharest, Romania.
ORCID-Profile: Roxana Andra Coman, Liviuta Budisan, Ioana Berindan-Neagoe
Zitieren
APA
Coman, R. A., Nutu, A., Strilciuc, S., Budisan, L., & Berindan-Neagoe, I. (2025). Molecular Cargo of Exosomes in Prostate Cancer: A Multi-Omics Perspective on Liquid Biopsies. Genes, 16(12), 1437. https://doi.org/10.3390/genes16121437
Vancouver
Coman RA, Nutu A, Strilciuc S, Budisan L, Berindan-Neagoe I. Molecular Cargo of Exosomes in Prostate Cancer: A Multi-Omics Perspective on Liquid Biopsies. Genes. 2025;16(12):1437. doi:10.3390/genes16121437
BibTeX
@article{Coman2025,
author = {Coman, Roxana Andra and Nutu, Andreea and Strilciuc, Stefan and Budisan, Liviuta and Berindan-Neagoe, Ioana},
title = {Molecular Cargo of Exosomes in Prostate Cancer: A Multi-Omics Perspective on Liquid Biopsies},
journal = {Genes},
year = {2025},
volume = {16},
number = {12},
pages = {1437},
doi = {10.3390/genes16121437}
}
EUVIMED